Label: SENNA-S tablet

  • NDC Code(s): 72090-030-20
  • Packager: Pioneer Life Sciences, LLC
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph not final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated October 3, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • Active Ingredients (in each tablet)

    Docusate Sodium 50 mg

    Sennosides 8.6 mg

  • Purpose

    Stool softener

    Laxative

  • Uses:

    • Relieves occasional constipation (irregularity).
    • Generally produces a bowel movement in 6 to 12 hours.
  • Warnings:

    Do not use: If you are now taking mineral oil, unless directed by a doctor. Laxative products for longer than 1 week, unless directed by a doctor.

  • ASK DOCTOR

    Ask a doctor before use if you have: 

    • Stomach pain
    • nausea
    • vomiting
    • Noticed a sudden change in bowel habits that continues over a period of 2 weeks.
  • STOP USE

    Stop use and ask a doctor if you have:

    • Rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.
  • PREGNANCY OR BREAST FEEDING

    • If pregnant or breast-feeding, ask a health professional before use.
  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

  • DIRECTIONS

    Take preferably at bedtime or as directed by a doctor.

    age

    starting dosage

    maximum dosage

    adults & children 12 years of age and over

    2 tablets once a day

    4 tablets twice a day

    children 6 to under 12 years

    1 tablet once a day

    2 tablets twice a day

    children 2 to under 6 years

    1 /2 tablet once a day

    1 tablet twice a day

    children under 2 years

    ask a doctor

    ask a doctor

  • OTHER INFORMATION

    • Each tablet contains: Calcium 19.92 mg, Sodium 5.61 mg VERY LOW SODIUM
    • store at 25°C (77°F) excursions permitted between15°-30°C (59°-86°F)
  • INACTIVE INGREDIENTS

    Croscarmellose Sodium, Colloidal Silicon Dioxide, Dicalcium Phosphate, F D & C Red, Hypromellose, Magnesium Stearate,
    Microcrystalline Cellulose, Maltodextrin, Polyethylene Glycol, Stearic acid Powder, Titanium Dioxide.

  • QUESTIONS OR COMMENTS?

    Call toll-free 1 (732) 689-5070 Monday through Friday 9 am to 5 pm EST.

  • PRINCIPAL DISPLAY PANEL

    Senna-S-Senokot-200ct.jpg

  • INGREDIENTS AND APPEARANCE
    SENNA-S 
    senna-s tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72090-030
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG) DOCUSATE SODIUM50 mg
    SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.6 mg
    Inactive Ingredients
    Ingredient NameStrength
    Croscarmellose Sodium (UNII: M28OL1HH48)  
    Silicon Dioxide (UNII: ETJ7Z6XBU4)  
    ANHYDROUS DIBASIC CALCIUM PHOSPHATE (UNII: L11K75P92J)  
    FD&C RED NO. 3 (UNII: PN2ZH5LOQY)  
    HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
    Magnesium Stearate (UNII: 70097M6I30)  
    Microcrystalline Cellulose (UNII: OP1R32D61U)  
    Maltodextrin (UNII: 7CVR7L4A2D)  
    POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    Titanium Dioxide (UNII: 15FIX9V2JP)  
    Product Characteristics
    ColorredScoreno score
    ShapeROUNDSize10mm
    FlavorImprint Code none
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:72090-030-20200 in 1 BOTTLE; Type 0: Not a Combination Product06/29/2020
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph not finalpart33406/29/2020
    Labeler - Pioneer Life Sciences, LLC (014092742)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!